Inventor · disambiguated record
Hong Xiang
Also filed as: XIANG HONG · XIANG HONG BING
7 granted patents·14 pending applications·7 citations·filing 2001–2024
75Inventor score
Files withFIVE PRIME THERAPEUTICS INC10GENENTECH INC33M INNOVATIVE PROPERTIES CO2NANJING PEIXUAN YAPU OPTOELECTRONIC TECH CO LTD2ESCANDON ENRIQUE1
Top patents by PatentIndex Score
21 records- 0183US11091555B2Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapyFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·3 cites·20 claims
- 0275US2024317864A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0369US2023287123A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0468US10976566B2Optical imaging equipment and methodNANJING PEIXUAN YAPU OPTOELECTRONIC TECH CO LTD·Filed 2019·Granted Apr 13, 2021·2 cites·10 claims
- 0568US2009169569A1APO-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2008·Application pending·0 cites
- 0667US12319738B2Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancerFIVE PRIME THERAPEUTICS INC·Filed 2021·Granted Jun 3, 2025·0 cites·12 claims
- 0766US10975153B2Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2015·Granted Apr 13, 2021·1 cites·29 claims
- 0862US11327285B2Illumination method and equipment for optical imagingNANJING PEIXUAN YAPU OPTOELECTRONIC TECH CO LTD·Filed 2021·Granted May 10, 2022·1 cites·4 claims
- 0961US10329700B2Method for producing a fluffy temperature regulating warmth retention material and fluffy temperature regulating warmth retention material3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Jun 25, 2019·0 cites·20 claims
- 1060US2021070862A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1157US2021317219A1Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1255US12204741B2Screenshot method and related deviceHUAWEI TECH CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·20 claims
- 1351US2017231310A1Stuffing and manufacturing method thereof3M INNOVATIVE PROPERTIES CO·Filed 2015·Application pending·0 cites
- 1450US2004005314A1Apo-2l receptor agonist and cpt-11 synergismESCANDON ENRIQUE·Filed 2001·Application pending·0 cites
- 1550US2021332137A1Combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1648US2011059104A1Apo-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2010·Application pending·0 cites
- 1748US2011262436A1Treatment methodGENENTECH INC·Filed 2009·Application pending·0 cites
- 1848US2025179173A1Combination therapy of lilrb antagonist and pd-1/pd-l1 axis inhibitorIMMUNE ONC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1947US2020288795A1Filtering mask with anti-counterfeit functionHONEYWELL INT INC·Filed 2017·Application pending·0 cites
- 2042US2023382972A9Cd80 extracellular domain fc fusion protein regimensFIVE PRIME THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2140US2021340214A1Cd80 extracellular domain fc fusion protein dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hong Xiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →